Annual EBIT
$94.78 M
+$14.36 M+17.86%
March 31, 2022
Summary
- As of February 10, 2025, CO annual earnings before interest & taxes is $94.78 million, with the most recent change of +$14.36 million (+17.86%) on March 31, 2022.
- During the last 3 years, CO annual EBIT has risen by +$37.89 million (+66.59%).
Performance
CO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
$22.36 M
-$1.03 M-4.42%
March 31, 2022
Summary
- As of February 10, 2025, CO quarterly earnings before interest & taxes is $22.36 million, with the most recent change of -$1.03 million (-4.42%) on March 31, 2022.
- Over the past year, CO quarterly EBIT has dropped by -$486.70 thousand (-2.13%).
Performance
CO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
$94.76 M
-$486.70 K-0.51%
March 31, 2022
Summary
- As of February 10, 2025, CO TTM earnings before interest & taxes is $94.76 million, with the most recent change of -$486.70 thousand (-0.51%) on March 31, 2022.
- Over the past year, CO TTM EBIT has increased by +$14.29 million (+17.76%).
Performance
CO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | -2.1% | +17.8% |
| 3 y3 years | +66.6% | +69.9% | +31.8% |
| 5 y5 years | +123.7% | +135.6% | +31.8% |
CO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -15.2% | -4.4% | at low | -0.5% | at low |
| 5 y | 5-year | at high | -40.0% | -9.7% | -16.4% | -0.5% | -24.1% |
| alltime | all time | at high | -101.8% | -9.7% | -105.2% | -0.5% | -102.0% |
Global Cord Blood EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | $94.78 M(+17.9%) | $22.36 M(-4.4%) | $94.76 M(-0.5%) |
| Dec 2021 | - | $23.40 M(-5.6%) | $95.25 M(+5.2%) |
| Sep 2021 | - | $24.78 M(+2.3%) | $90.55 M(+5.4%) |
| Jun 2021 | - | $24.23 M(+6.0%) | $85.87 M(+6.7%) |
| Mar 2021 | $80.42 M(+0.2%) | $22.85 M(+22.2%) | $80.47 M(+1.8%) |
| Dec 2020 | - | $18.70 M(-7.0%) | $79.01 M(-3.7%) |
| Sep 2020 | - | $20.10 M(+6.7%) | $82.02 M(-0.6%) |
| Jun 2020 | - | $18.83 M(-12.0%) | $82.51 M(+2.9%) |
| Mar 2020 | $80.25 M(+41.1%) | $21.39 M(-1.4%) | $80.15 M(+11.4%) |
| Dec 2019 | - | $21.70 M(+5.4%) | $71.92 M(+13.1%) |
| Sep 2019 | - | $20.59 M(+25.0%) | $63.61 M(+8.9%) |
| Jun 2019 | - | $16.47 M(+25.2%) | $58.42 M(+2.6%) |
| Mar 2019 | $56.90 M(+22.4%) | $13.16 M(-1.7%) | $56.93 M(+10.7%) |
| Dec 2018 | - | $13.39 M(-13.0%) | $51.44 M(+0.8%) |
| Sep 2018 | - | $15.39 M(+2.7%) | $51.03 M(+6.1%) |
| Jun 2018 | - | $14.98 M(+95.4%) | $48.11 M(+4.4%) |
| Mar 2018 | $46.48 M(+9.7%) | $7.67 M(-40.9%) | $46.10 M(-3.8%) |
| Dec 2017 | - | $12.98 M(+4.0%) | $47.92 M(-4.2%) |
| Sep 2017 | - | $12.48 M(-3.7%) | $50.00 M(+7.6%) |
| Jun 2017 | - | $12.97 M(+36.6%) | $46.48 M(+10.2%) |
| Mar 2017 | $42.37 M(+8.1%) | $9.49 M(-37.0%) | $42.20 M(+6.8%) |
| Dec 2016 | - | $15.06 M(+68.1%) | $39.52 M(+1.6%) |
| Sep 2016 | - | $8.96 M(+3.3%) | $38.89 M(-0.6%) |
| Jun 2016 | - | $8.68 M(+27.3%) | $39.14 M(-0.2%) |
| Mar 2016 | $39.20 M(-5.2%) | $6.82 M(-52.8%) | $39.23 M(-4.6%) |
| Dec 2015 | - | $14.44 M(+56.7%) | $41.10 M(+6.7%) |
| Sep 2015 | - | $9.21 M(+5.1%) | $38.52 M(-2.4%) |
| Jun 2015 | - | $8.76 M(+0.7%) | $39.47 M(-4.6%) |
| Mar 2015 | $41.34 M | $8.70 M(-26.6%) | $41.36 M(-6.1%) |
| Dec 2014 | - | $11.85 M(+16.6%) | $44.07 M(+0.4%) |
| Sep 2014 | - | $10.16 M(-4.7%) | $43.89 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $10.66 M(-6.5%) | $43.72 M(+2.4%) |
| Mar 2014 | $42.66 M(+17.7%) | $11.40 M(-2.3%) | $42.68 M(+6.1%) |
| Dec 2013 | - | $11.67 M(+16.9%) | $40.21 M(+0.3%) |
| Sep 2013 | - | $9.99 M(+3.9%) | $40.10 M(+5.6%) |
| Jun 2013 | - | $9.62 M(+7.6%) | $37.96 M(+4.6%) |
| Mar 2013 | $36.26 M(+49.9%) | $8.93 M(-22.7%) | $36.29 M(+8.2%) |
| Dec 2012 | - | $11.56 M(+47.3%) | $33.55 M(+19.9%) |
| Sep 2012 | - | $7.85 M(-1.3%) | $27.98 M(+8.6%) |
| Jun 2012 | - | $7.95 M(+28.4%) | $25.77 M(+6.5%) |
| Mar 2012 | $24.19 M(+20.7%) | $6.19 M(+3.3%) | $24.19 M(+0.9%) |
| Dec 2011 | - | $6.00 M(+6.4%) | $23.96 M(+1.7%) |
| Sep 2011 | - | $5.63 M(-11.5%) | $23.57 M(+3.8%) |
| Jun 2011 | - | $6.37 M(+6.7%) | $22.71 M(+13.0%) |
| Mar 2011 | $20.04 M(+66.6%) | $5.97 M(+6.5%) | $20.10 M(+12.6%) |
| Dec 2010 | - | $5.60 M(+17.3%) | $17.85 M(+9.8%) |
| Sep 2010 | - | $4.78 M(+27.1%) | $16.26 M(+5.9%) |
| Jun 2010 | - | $3.76 M(+1.2%) | $15.36 M(+27.7%) |
| Mar 2010 | $12.03 M(-807.4%) | $3.71 M(-7.5%) | $12.03 M(+50.1%) |
| Dec 2009 | - | $4.01 M(+3.7%) | $8.01 M(+182.6%) |
| Sep 2009 | - | $3.87 M(+802.2%) | $2.84 M(-311.6%) |
| Jun 2009 | - | $429.00 K(-242.6%) | -$1.34 M(-28.5%) |
| Mar 2009 | - | -$300.80 K(-74.1%) | -$1.88 M(+8.9%) |
| Dec 2008 | -$1.70 M(+205.6%) | -$1.16 M(+281.3%) | -$1.72 M(+148.5%) |
| Sep 2008 | - | -$305.10 K(+187.3%) | -$693.40 K(+31.3%) |
| Jun 2008 | - | -$106.20 K(-28.4%) | -$528.10 K(-10.7%) |
| Mar 2008 | - | -$148.30 K(+10.8%) | -$591.10 K(+5.1%) |
| Dec 2007 | -$556.50 K(+1805.8%) | -$133.80 K(-4.3%) | -$562.40 K(+31.2%) |
| Sep 2007 | - | -$139.80 K(-17.4%) | -$428.60 K(+48.4%) |
| Jun 2007 | - | -$169.20 K(+41.5%) | -$288.80 K(+141.5%) |
| Mar 2007 | - | -$119.60 K | -$119.60 K |
| Dec 2006 | -$29.20 K | - | - |
FAQ
- What is Global Cord Blood annual earnings before interest & taxes?
- What is the all time high annual EBIT for Global Cord Blood?
- What is Global Cord Blood annual EBIT year-on-year change?
- What is Global Cord Blood quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Global Cord Blood?
- What is Global Cord Blood quarterly EBIT year-on-year change?
- What is Global Cord Blood TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Global Cord Blood?
- What is Global Cord Blood TTM EBIT year-on-year change?
What is Global Cord Blood annual earnings before interest & taxes?
The current annual EBIT of CO is $94.78 M
What is the all time high annual EBIT for Global Cord Blood?
Global Cord Blood all-time high annual earnings before interest & taxes is $94.78 M
What is Global Cord Blood annual EBIT year-on-year change?
Over the past year, CO annual earnings before interest & taxes has changed by +$14.36 M (+17.86%)
What is Global Cord Blood quarterly earnings before interest & taxes?
The current quarterly EBIT of CO is $22.36 M
What is the all time high quarterly EBIT for Global Cord Blood?
Global Cord Blood all-time high quarterly earnings before interest & taxes is $24.78 M
What is Global Cord Blood quarterly EBIT year-on-year change?
Over the past year, CO quarterly earnings before interest & taxes has changed by -$486.70 K (-2.13%)
What is Global Cord Blood TTM earnings before interest & taxes?
The current TTM EBIT of CO is $94.76 M
What is the all time high TTM EBIT for Global Cord Blood?
Global Cord Blood all-time high TTM earnings before interest & taxes is $95.25 M
What is Global Cord Blood TTM EBIT year-on-year change?
Over the past year, CO TTM earnings before interest & taxes has changed by +$14.29 M (+17.76%)